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Cimetidine is an imidazole derivative, which acts as H2-receptor antagonist to inhibit gastric acid 
secretion and is thereby useful in the treatment of ulcers and other hyperacidity stomach disorders. This study 
sets out to provide simple, inexpensive and sensitive analytical techniques for the assay of cimetidine in tablet 
dosage forms using first derivative potentiometric and UV-spectrophotometric techniques, with a view to 
providing simple, sensitive and cost-effective analytical methods. Ten brands of cimetidine tablets were 
purchased from pharmacies in Yenagoa and Port Harcourt, Niger Delta region of Nigeria. The samples were 
assayed by Potentiometric and UV spectrophotometric methods after a Thin Layer Chromatographic (TLC) 
fingerprint. The potentiometric assay results of the samples ranged from 92-100% of stated amount for 70% of 
the samples. The coefficient of variation for In-betw en run, Intra-day run and accuracy of the UV 
spectrophotometric method was within 3%. The percentage purity of cimetidine from UV determination at 260 
nm ranged from 86 - 97%, showing that 50% of the samples conformed to the stated standard – ie: contain 95-
105% of stated amount. The TLC fingerprints of the samples were similar in many respects, including Rf 
values which ranged from 0.8 to 0.9 compared to the reference sample with Rf value of 0.9. The results suggest 
that either of the two methods can be fine-tuned for assay of cimetidine in tablet formulations. 
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Proliferation of substandard and 
adulterated pharmaceutical products is a 
global phenomenon, which has been of great 
concern to many countries including Nigeria. 
The resurgence of substandard drug products 
especially, in Nigeria is as a result of a 
number of factors, which include poor drug 
procurement and distribution, low literacy 
level, inadequate information on the 
circulation of substandard products, lack of 
facilities for effective quality control analysis 
as an important element in quality 
surveillance and ineffectiveness of drug 
regulatory authorities (Clarke, 2002). These 
problems have being further compounded in 
Nigeria that imports most drugs from Asian 
countries like China and India. The World 
Health Organisation (WHO) rose to the 
challenge by recommending that all importing 
countries should protect themselves from this 
menace by undertaking sampling of products 
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within the distribution network as an 
important element in quality surveillance 
(WHO, 1996).    
Cimetidine, a H2-receptor antagonist is 
an imidazole. The full name is: 2-Cyano -1-
methyl -3-[2-S-methyl imidazole -4- yl methyl 
thio] ethyl guanidine (Figure 1). It acts as H2-
receptor antagonist and inhibits gastric acid 
secretion, being particularly effective against 
the nocturnal acid secretion (Harvey and 
Champe, 2009).  
It acts by competitively blocking the 
binding of histamine to H2- receptors. It binds 
selectively to the histamine-H2-receptor on the 
basolateral membrane of the parietal cells. 
Cimetidine inhibits acetylcholine and gastrin 
mediated acid responses (Brown, 2003). It 
reduces the intracellular concentration of 
cAMP, ie: cyclic adenosine monophosphate 
(Harvey and Champe, 2009). Cimetidine is 
active against duodenal ulcer, benign gastric 
ulcer, recurrent stomach ulceration, 
oesphageal reflux disease and other condition 
where reduction of gastric acid is beneficial. 
A variety of methods both official and 
non-official have been used to analyze raw 
cimetidine and cimetidine formulations. A 
quantitative method using silica gel HPLC 
plate with fluorescent indicator, automated 
sample application and UV absorptions 
developed for the determination of cimetidine 
have been reported. The method was precise 
with precision range of 1.2%-2.2% relative 
standard deviation and the error in the 
standard additional analysis was 0.985% 
compared to the fortification level (Colin-
Jones et al., 1985). Although the authors 
emphasized the sensitivity of the HPLC 
method over other techniques including 
potentiometric method, which is the BP 
method, they acknowledge the demerit of high 
cost and complexity of operations involved. 
The potentiometric titration method 
using 0.1M perchloric acid (VS) is 
economical, easily available and it is one of 
the official methods for the analysis of 
cimetidine (BP 2008). This method avoids the 
interference of the excipients since the 
completion of the reaction is detected through 
the slope change of the electromotive force 
(EMF) or the pH versus the volume of the 
titrant. Thus, potentiometric titration and UV 
spectrophotometric methods are suitable for 
cimetidine analysis. A 0.1M perchloric acid 
VS is one whose actual concentration is 
accurately determined. 
 
MATERIALS AND METHODS  
Materials 
Cimetidine reference standard (Sigma-
Aldrich, USA), glacial acetic acid (BDH), 
perchloric acid (BDH), sulphuric acid, 
distilled water, crystal violet and distilled 
water, methanol (Sigma Aldrich), and 
ethylacetate (BDH). Ten brands of cimetidine 
of tablet were procured from Pharmacies in 
Yenagoa and Port-Harcourt, Niger Delta 
Region of Nigeria and were coded A to J. 
Their batch and official registration 
(NAFDAC) numbers and the address of the 
manufacturer for each brand as well as their 
corresponding manufacturing and expiry dates 
were duly documented. 
 
Equipment 
These include analytical weighing 
balance (Galenkamp), burettes, UV 
spectrophotometer (Shimadzu, Japan), 
measuring cylinder, potentiometer 
(Galenkamp), volumetric flask, beakers, 
pipettes, conical flask, retort stands, TLC 
plates and iodine tank. 
 
Methods 
Weight uniformity test 
Ten tablets (10) of samples A to J were 
accurately weighed one after the other using 
an analytical balance and the respective 
weights were recorded. The average weights, 
weight variation, standard deviation and 
percentage deviation of the respective brands 
were calculated.  
Thin layer chromatography 
Cimetidine (0.5 g) was dissolved in 10 
ml of methanol, which is used as the sample 
solution. 1 ml of this was pipetted and 
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methanol was added to make exactly 10 ml, 
which is used as the standard solution. Each of 
the sample solution and the standard solution 
was spotted on a TLC plate. After much trials 
in developing the solvent system in ratios, 
ratios such as ethylacetate: methanol; (50:50), 
ethylacetate methanol (70:30), ethylacetate: 
methanol (60:40), the TLC plate was 
developed with a mixture, of ethylacetate and 
methanol in the ratio (80:20) to a distance of 
15cm. The plate was air dried and then dried 
in the ovum at 80 oC for about 30 mins. The 
plate was allowed to stand mix with iodine 
vapour for 45 mins. The distance moved by 
the sample and the distance moved by the 
solvent were measured. 
Potentiometric titration 
The pH meter was standardized against 
a buffer solution of pH 4. Powdered 
cimetidine tablet (0.276 g) was weighed and 
then dissolved in 60ml of acetic acid in a 
volumetric flask. A burette was filled with 
0.1M perchloric acid. The pH of the drug was 
first determined then, perchcloric acid (0.1M) 
was added in drops and it was stirred with 
each dropping into the beaker and pH change 
was noted. As there was an increase in pH, the 
amount of titrant added was reduced to 0.5ml, 
this was followed by a sharp drop in the pH 
indicating nearness to the endpoint. This 
procedure was repeated for all the other 
samples. A graph of the mean pH of the 
solution was plotted against the volume of 
titrant for samples A to J to determine the 
equivalence point. 
 
U.V Spectrophotometric analysis  
Preparation of cimetidine standard stock 
solution 
500 mg of standard cimetidine was 
weighed and transferred into a beaker were it 
was dissolved with 0.1M H2SO4 and filtered. 
The resultant solution was transferred into a 
50ml volumetric flask and it was made up to 
mark with 0.1M H2SO4 solution to give a 
stock concentration of 10 mg/ml. A portion of 
the solution was scanned between 220-350 
nm. 
Calibration curve for cimetidine 
From the stock solution (10 mg/ml) of 
cimetidine, serial dilutions were made in 
aqueous 0.1M H2SO4 to give the following 
concentrations; 1 mg/ml, 2 mg/ml, 4 mg/ml, 6 
mg/ml, 8 mg/ml and 10 mg/ml. The 
absorbance of these concentrations were 
measured and recorded at 260 nm. The graph 
of absorbance was plotted against the 
concentration using Microsoft excel 2007 
version. 
Preparation of test sample 
A weight equivalent to 500 mg of 
powdered cimetidine test sample A was 
weighed and transferred into a beaker were it 
was dissolved with some 0.1 M H2SO4 
solutions and filtered. The resultant solution 
was transferred into a 50 ml volumetric flask 
and it was made up to mark with 0.1M H2SO4 
solution to give a stock concentration of 10 
mg/ml. From the prepared stock solution, 
concentrations of 1 mg/ml and 10 mg/ml were 
prepared using a micro-pipette and there UV 
absorbance was measured at the λmax of 260 
nm. This procedure was repeated for brands B 
to J. The absorbance was extrapolated on the 
calibration curve and the percentage content 
of each of the test samples was calculated. 
 
Statistical analysis 
Student t-test in the SPSS statistical 
software programme was used to compare the 
UV spectrophotometric and potentiometric 
methods assay results in this study with p < 
0.05 as the level of significance. 
 
RESULTS 
Uniformity of weight 
The percentage deviation of each tablet 
from the average weight for the samples A–J 
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Thin layer chromatographic method 
The Rf value, which is calculated as the 
ratio of the distance moved by drug sample 
against the distance moved by the solvent 
front of the reference standard of cimetidine 
and the test samples A to J are shown in Table 
1. 
 
Potentiometric titration of cimetidine 
tablets samples A to J 
The equivalence point of the 
potentiometric titrations of cimetidine samples 
A to J were determined graphically by a plot 
of the pH changes against the volume of 
titrant. Figure 2 shows a representative graph 
of the mean pH changes against volume of 
titrant while Figure 3 indicates the First 
derivative potentiometric graph for samples A 
to J. The % purity for samples A–J were 
calculated by dividing the equivalence point 
of each sample by the equivalence point of 
reference standard multiplied by a 100 as 
shown in Table 2.  
Figure 4 shows a chart indicating a 
comparative result of potentiometric titrations 
and UV spectrophotometric method for the 
assay of cimetidine tablets samples A to J. 
 
UV-spectrophotometric method 
Standard curve for cimetidine 
The calibration curve for the standard 
ciprofloxacin was linear over a concentration 
range of 1.0 to 10 mg/ml with the regression 
line equation obtained as y = 0.085x + 0.031, 
which was in line with the Beer-Lambert’s 
law. 
Precision of the analytical method 
The coefficient of variation, which is a 
measure of the precision, was < 2% for In-
between run and was < 3% for the Intra-day 
run, which is a measure of reproducibility of 
the method for cimetidine (Table 3). Also, the 
relative error (%), an indicator of accuracy 
was within 3%. 
Percentage purity for cimetidine test samples 
The percent purity of samples A to J 
was calculated using the regression equation 
obtained from the standard curve by UV 
spectrophotometry is shown in Table 4. 
Samples A–J showed % purity, which ranged 
from 85.5 to 97.3% with the highest % 
deviation of approximately 3% from the mean 












Figure 1: Chemical structure of cimetidine 
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 Table 1: TLC Rf values of standard cimentidine and test samples A to J. 
 
Samples Distance moved by solvent Distance move by the drug Rf 
A 6.0 5.4 0.9 
B 6.0 5.4 0.9 
C 6.0 5.4 0.9 
D 6.0 5.4 0.9 
E 6.0 5.2 0.8 
F 6.0 5.0 0.8 
G 6.0 5.4 0.9 
H 6.0 5.4 0.9 
I 6.0 5.2 0.8 
J 6.0 5.0 0.8 
 
 
Table 2: Percentage purity for samples A to J following potentiometric titration. 
 
Sample Volume of titrant (ml) % Purity 
A 7.92 100.0% 
B 7.90 99.70% 
C 7.40 93.40% 
D 7.90 99.7% 
E 7.92 100.0% 
F 7.30 92.2% 
G 7.40 93.4% 
H 7.90 99.7% 
I 7.91 99.9% 
J 7.92 100.0% 
 
 






conc. ± SD (µg/ml) 






1.05 ± 0.014 
4.92 ± 0.058 








0.98 ± 0.025 
5.05 ± 0.047 








1.04 ± 0.024 
4.97 ± 0.046 
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A 0.103 0.867 0.85 9.84 5.35 97.3 
B 0.102 0.851 0.84 9.65 5.25 95.5 
C 0.103 0.778 0.85 8.79 4.82 87.6 
D 0.1 0.852 0.81 9.66 5.24 95.3 
E 0.103 0.865 0.85 9.81 5.33 96.0 
F 0.102 0.851 0.84 9.65 5.25 95.5 
G 0.1 0.861 0.81 9.76 5.29 96.2 
H 0.102 0.762 0.84 8.6 4.72 85.8 
I 0.102 0.862 0.84 9.78 5.31 96.5 










Figure 2: Mean potentiometric titration curve for sample A to J. 











Figure 4: A chart of assay results using potentiometry and uv-spectrophotometry for cimetidine 




Potentiometric and UV 
spectrophotometric were employed in 
analyzing ten different brands of cimetidine 
tablet in this study to ascertain that the 
products contain the required amount of the 
active ingredients and to investigate the 
possibility that passing or failing a quality 
control analysis by a pharmaceutical 
preparation may result from the inefficiency 
or limitation of the analytical method used.  
The weight uniformity test carried out 
showed that all the brands of cimetidine 
passed the test, with no sample exceeding the 
± 5% deviation, as specified in the official 
compendia (USP, 2006; BP, 2008). The TLC 
fingerprint for the respective brands showed 
elution, colour change, change in size of 
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principal spot and Rf values ranging from 0.8 - 
0.9. When compared with reference standard 
that gave Rf value of 0.9, all the samples fell 
within the range ≤ 0.9 point. 
In potentiometric titration, the potential 
of an indicator electrode is measured as a 
function of the volume of the titrant. The 
equivalence point of the reaction is shown by 
a sudden change in the potential. This is 
shown by the plot of the pH reading against 
the volume of titrant (Figure 2). In situations 
where the change in EMF or pH is not sharp 
at the end point, it is difficult to determine it 
accurately. Therefore, to determine the end 
point more precisely, a plot of first derivative 
curve, δpH/δv against BRa + BRb/2. Where, 
δpH represents change in pH on addition of δv 
ml of titrant (δv= BRa + BRb); BRb is burette 
readings before addition of a small volume of 
a titrant and BRa is burette readings after 
addition of a small volume of titrant. The 
accuracy of the plots and calculations in 
potentiometric titrations are enhanced by 
using small, constant volumes of the titrant 
during titration, especially near and after the 
end point as shown in Figure 3.  
Potentiometric assay result of cimetidine 
tablet samples ranged from 92.2-100%, which 
indicates that 70% of the samples conformed 
to the stated limit of 96-105% (BP, 2008). 
Samples C, F and G had values slightly below 
the lower limit of the required range.  
The standard cimetidine was scanned 
within the UV-VIS region for the maximum 
wavelength (ƛmax) of absorption, which was 
found to be 260nm. This ƛmax of cimetidine 
made it possible to monitor the concentrations 
of cimetidine in the test samples with little or 
no interference. The calibration curve was 
linear over the concentration range of 1 mg/ml 
to 10 mg/ml and the regression coefficient 
(R2=0.992) allowed for accurate determination 
of the concentration and hence percent purity 
of test samples A to J. The coefficient of 
variation (%), an indicator of precision and 
the relative error (%), a measure of accuracy 
of the analytical method, which were 
evaluated by replicate analyses of the pure 
drug solution at three different concentrations 
within working range, indicates high precision 
and accuracy of the method. The intra-day 
precision, which is a measure of the 
reproducibility of the method with coefficient 
of variation being less than 3% shows that the 
method was highly reproducible. The 
spectrophotometric method was therefore 
sensitive and reproducible.  
The assay of samples A–J by UV 
spectrophotometric method gave results 
ranging from 85.5-97.3%, which shows that 
not all the samples were within the BP limits. 
Samples C, H and J with % purity of 87.6%, 
85.8%, and 85.5%, respectively, are far below 
the lower required limit of 95% and could be 
said to be substandard while samples D and F 
with % purity of 95.3% and 95.5%, 
respectively were slightly less than the lower 
required limit, which may result from 
experimental limits. Overall, 50% of the 
cimetidine tablet samples assayed using the 
UV method had % purity within the stated 
official requirement. The findings of 
suboptimal amount and overage in the test 
samples may stem from under incorporation 
of active ingredient, poor formulation, poor 
storage facilities since presence of 
chromophores in drug substances makes them 
light sensitive, adulteration and possible 
inefficiency of the UV spectophotometer.  
Comparing the potentiometric and 
spectrophotometric methods, it was observed 
that samples C and F failed to meet the stated 
requirement for both methods while sample G 
passed the uv spectrophotometric assay it 
failed to meet the stated standard using 
potentiometric analysis (Figure 4). However, 
TLC fingerprint, a useful tool in identifying of 
the active ingredient of a drug formulation did 
not justify these findings.  The finding in this 
study shows that potentiometry, and UV 
spectrophotometry though relatively 
inexpensive and simple compared to HPLC 
assay method (Colin-Jones et al., 1985) could 
be effective in the determination of the quality 
of active ingredients in cimetidine tablet.  
 




Authenticity of pharmaceutical 
products is measured based on the compliance 
with official standards as stated in 
monographs.  As far as identification and 
assay of cimetidine tablet are concerned, this 
study proved that TLC and any of the two 
analytical methods (potentiometry and 
spectrophotometry) can be applied to evaluate 
the quality of cimetidine tablet formulations. 
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